Aplicare Povidone Iodine Prep Pads packaged within Portex Pulsator Arterial Blood Sampling Kit wi...

FDA Device Recall #Z-0843-2019 — Class II — June 22, 2018

Recall Summary

Recall Number Z-0843-2019
Classification Class II — Moderate risk
Date Initiated June 22, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Smiths Medical ASD Inc.
Location Minneapolis, MN
Product Type Devices
Quantity Approx. 28,578,939 kits for both products

Product Description

Aplicare Povidone Iodine Prep Pads packaged within Portex Pulsator Arterial Blood Sampling Kit with Liquid Sodium Heparin, models 4037NP-1, 4039-1, 4039EG-1, 4044EG-1, 4044P-1, 4057NP-1, 4067NP-1, 4077EG-1, 4077NP-1, 4084P-1, G1193, G1374, G1585, G1589, G1598, G1621, and G1806. The firm name on the label is Smiths Medical ASD, Inc., Keene, NH.

Reason for Recall

The povidone iodine prep pads packaged with the arterial blood sampling kits will not maintain the iodine potency through its labeled 36-month expiration dating.

Distribution Pattern

Distribution was nationwide, including Puerto Rico. There was also military/government distribution. Foreign distribution was made to Canada, United Arab Emirates, Bahamas, Costa Rica, Latvia, and Saudi Arabia.

Lot / Code Information

Product with expiration dates between 11/30/2016 and 5/31/2020.

Other Recalls from Smiths Medical ASD Inc.

Recall # Classification Product Date
Z-0147-2025 Class II smiths medical portex, Thermovent 1200, 15mm/22... Jul 18, 2024
Z-0145-2025 Class II smiths medical portex, Y' PIECE 15MM, REF 100/2... Jul 18, 2024
Z-0146-2025 Class II smiths medical portex, 'ORATOR' SPEAKING VALVE ... Jul 18, 2024
Z-0143-2025 Class II smiths medical portex, Nasopharyngeal Airway, S... Jul 18, 2024
Z-0144-2025 Class II smiths medical portex, 15mm Double Swivel Conne... Jul 18, 2024

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.